NewsRx

Search our medical news database

Cervical Cancer

HIV infection associated with increased risk of cervical cancer precursor

Published in Women's Health Weekly, February 9th, 2006

Women infected with HIV types 1 and 2 may have a higher risk of high-grade cervical squamous intraepithelial lesions (HSILs) than HIV negative women, according to a new study in Senegalese women.

Stephen E. Hawes, PhD, of the University of Washington in Seattle, and colleagues studied a cohort of 627 women with and without HIV types 1 and/or 2 and/or high-risk human papillomavirus (HPV) infection in Senegal, West Africa. They followed the women for a mean of 2.2 years with evaluations every 4 months.

They found that women infected with both HIV and a high-risk HPV type were at greatest risk of developing a cervical cancer precursor called HSIL. HIV...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook